Vectura Group Share Price (VEC)

134.80 -0.50 (-0.37%) delayed: 2:05PM BST
Bid price 134.50 Open price 135.50
Ask price 134.80 Prev close 134.80
High price 136.70 Spread 0.22%
Low price 133.20 Volume 1,359,721

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 134.80 Net Gearing (%) -17.92
Market Capitalisation (£m) 915.26 Gross Gearing (%) 17.01
Shares in issue (m) 677.47 Debt Ratio 8.28
P/E Ratio 112.58 Debt-to-Equity Ratio 0.44
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.21
Dividend Yield (%) 0.00 Price to book value 3.86
Dividend cover (x) 0.00 ROCE (%) -0.73
Earning per share (p) 1.20 EPS Growth (%) 33.33
52 week high / low 200.00 / 122.80 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
03/10/2016 BUY Susan Foden NED 6,500
30/09/2016 BUY Andrew Derodra FD 30,000
28/09/2016 EXR Dr Trevor Phillips ED 510,952
28/09/2016 SEXR Dr Trevor Phillips ED 240,841
27/09/2016 BUY Bruno Angelici CH 80,000

More Vectura Group Director Deals >>

Vectura Group Company News

16:16 19/10/2016


RNS Number : 9863M Vectura Group plc 19 October 2016     Vectura Group plc BLOCK LISTING RETURN   Date: 19 October 2016 Name of applicant: Vectura Group plc Block Listing Return for the period 1 April 2016 to 30 September 2016 Name of scheme (s)...

07:00 12/10/2016

Notice of Interim Results

RNS Number : 2823M Vectura Group plc 12 October 2016   Vectura Group plc Notice of Interim Results Chippenham, UK, 12 October 2016:  Vectura Group plc (LSE: VEC) ("the Group"), an industry-leading inhaled airways disease focused business, plans to announce its...

15:30 03/10/2016

Director Deals - Vectura Group PLC (VEC)

Susan Foden, Non Executive Director, bought 6,500 shares in the company on the 30th September 2016 at a price of 139.60p. The Director now holds 17,500 shares representing 0.00% of the shares in issue. Story provided by Director deals data provided by

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

1 months ago


Powered by IST's

Register now for FREE Vectura Group share price discussions